Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 3, 2011, Pages

  de Miguel, Carmen ^a   Guo, Chuanling ^a   Lund, Hayley ^a   Feng, Di ^a   Mattson, David L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chronic renal insufficiency; Reactive oxygen species generation

Indexed keywords

ALBUMIN; GLUCOSE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE; TACROLIMUS; THIOBARBITURIC ACID REACTIVE SUBSTANCE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DIETARY INTAKE; HISTOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SALT INTAKE; T LYMPHOCYTE; URINARY EXCRETION; WESTERN BLOTTING;

EID: 79954495250     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00454.2010     Document Type: Article

References (50)

1. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJV, Dominiczak AF. Investigation into the sources of superoxide in human vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206-2212, 2000.
2. Beswick R, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781-786, 2001.
3. Bravo Y, Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B. Mycophenolate mofetil administration reduces renal inflammation, oxida-tive stress, and arterial pressure in rats with lead-induced hypertension. Am J Physiol Renal Physiol 293: F616-F623, 2007.
4. Cabassi A, Bouchard JF, Dumont EC, Girouard H, Le Jossec M, Lamontagne D, Besner JG, de Chaplain J. Effect of antioxidant treatments on nitrate tolerance delopment in normotensive and hypertensive rats. J Hypertens 18: 187-196, 2000.
5. Cathcart M. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Ar-terioscler Thromb Vasc Biol 24: 23-28, 2004.
6. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of Ang II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
7. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38: 606-611, 2000.
8. phox in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 279: H2234-H2240, 2000.
9. Cook LG, Chiasson VL, Long C, Wu GY, Mitchell BM. Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than its calcineurin effect. Kidney Int 75: 719-726, 2009.
10. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 298: R1136-R1142, 2010.
11. Dröge W. Free radicals in the physiologic control of cell function. Physiol Rev 82: 47-95, 2002.
12. Endemann D, Schiffrin EL. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 6: 85-89, 2004.
13. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 293: R251-R256, 2007.
14. Griendling K, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
15. Guzik T, Hoch N, Brown K, McCann L, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison D. Role of T cells in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007.
16. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
17. Herrera J, Ferrebuz A, García MacGregor E, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 17: 218-225, 2006.
18. Hisaki R, Fujita H, Saito F, Kushiro T. Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens 18: 707-713, 2005.
19. Jackson S, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818-827, 2004.
20. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP gp91-phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004.
21. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yama-saki Y, Masuoka N, Yamada M, Kira S, Makino H. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 68: 1018-1031, 2005.
22. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Par-mer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender and ethnicity. Hypertension 36: 878-884, 2000.
23. Li Q, Subbulakshmi V, Fields AP, Murray NR, Cathcart MK. Protein kinase C alpha regulates human monocyte O-2 production and low density lipoprotein lipid oxidation. J Biol Chem 274: 3764-3771, 1999.
24. Makino A, Skelton MM, Zou AP, Cowley AW Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 42: 25-30, 2003.
25. Mattson D, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48: 149-156, 2006.
26. Meng S, Roberts 2nd LJ, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732-R738, 2002.
27. Muller D, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Ham-pich F, Fiebeler A, Ju X, Finckenberg P, Theuer J, Viedt C, Kreuzer J, Heidecke H, Haller H, Zenke M, Luft F. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 161: 1679-1693, 2002.
28. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
29. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 292: F330-F339, 2007.
30. Park J, Touyz RM, Chen X, Schriffin EL. Chronic treatment with a superoxide dismutase mimetic prevents remodeling, and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15: 78-84, 2002.
31. Pechman K, Basile DP, Lund H, Mattson DL. Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 294: R1234-R1239, 2008.
32. Polla B, Bachelet M, Elia G, Santoro MG. Stress proteins in inflammation. Ann NY Acad Sci 851: 75-85, 1998.
33. Quiroz Y, Pons H, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Larfo R, Egido J, Johnson RJ, Rodriguez-Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthase inhibition. Am J Physiol Renal Physiol 281: F38-F47, 2001.
34. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Grien-dling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
35. Redón J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sáez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003.
36. Rodriguez-Iturbe B, Johnson RJ. The role of inflammatory cells in the kidney in the induction and maintenance of hypertension. Nephrol Dial Transplant 21: 260-263, 2006.
37. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 255-260, 2007.
38. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxi-dative stress, renal infiltration of immune cells and salt-sensitive hyper-tension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004.
39. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H. Role of NADPH oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87: 1195-1201, 2000.
40. Schnackenberg C, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2alpha. Hypertension 33: 424-428, 1999.
41. Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Multicenter AIDS Cohort Study. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19: 953-960, 2005.
42. Somers M, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
43. Takeda Y, Miyamori I, Furukawa K, Inaba S, Mabuchi H. Mechanisms of FK 506-induced hypertension in the rat. Hypertension 33: 130-136, 1999.
44. Taylor N, Cowley AW. Effects of renal medullary H2O2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 289: R1573-R1579, 2005.
45. Touyz R, Schiffrin EL. Increased generation of superoxide by angioten-sin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NADPH oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001.
46. Vaz S, Augusto O. Inhibition of myeloperoxidase-mediated protein nitration by tempol: kinetics, mechanism and implications. Proc Natl Acad Sci USA 105: 8191-8196, 2008.
47. Vaziri N, Dicus M, Ho N, Sindhu RK. Oxidative stress, and dysregula-tion of superoxide dismutase, NAD(P)H oxidase and xanthine oxidase in chronic renal insufficiency. Kidney Int 63: 179-185, 2003.
48. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36: 957-964, 2000.
49. Wu R, Millete E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycor-ticosterone acetate-salt hypertensive rats. J Hypertens 19: 741-748, 2001.
50. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108: 101-106, 1998.